Regulatory

Ahead of the July 2026 “joint review” of the U.S.-Mexico-Canada Agreement (“USMCA”), the United States, Mexico, and Canada have each launched public consultation processes to solicit input from stakeholders on the operation of the USMCA, and possible changes those governments should seek to the Agreement as part of the review.

Continue Reading The United States, Mexico, and Canada Launch Domestic Consultation Processes on Upcoming USMCA Review

In this increasingly growing digital landscape, companies are entrusted with vast amounts of sensitive personal information. From names and email addresses to browsing habits and location data, companies routinely collect users’ personal data all to enhance convenience and functionality, advertise products, personalize experiences for consumers, and improve services. Plaintiffs’ law

Continue Reading Insurance Considerations for Privacy Class Action Lawsuits in This Technology Driven World

Brazil’s National Institute of Intellectual Property (“INPI”) initiated a public consultation on new guidance for the review of patent applications related to artificial intelligence (“AI”). The draft guidance document consolidates three previous INPI regulations and best practices adopted by other patent offices.

Click here to read the full alert on

Continue Reading Brazilian Government Opens Consultation on Artificial Intelligence-Related Patent Applications

On September 9, President Trump’s Make America Healthy Again (MAHA) Commission, chaired by HHS Secretary Kennedy, released its “Make Our Children Healthy Again Strategy Report” (Strategy Report) as directed by Executive Order 14212 (EO), which established the MAHA Commission. A draft of this report was leaked to the public about

Continue Reading The Make Our Children Healthy Again Strategy Report: What it Says and Doesn’t Say about U.S. Food Regulation

On September 10, Senate Commerce, Science, and Transportation Committee Chair Ted Cruz (R-TX) released what he called a “light-touch” regulatory framework for federal AI legislation, outlining five pillars for advancing American AI leadership.  In parallel, Senator Cruz introduced the Strengthening AI Normalization and Diffusion by Oversight and eXperimentation (“SANDBOX”) Act

Continue Reading Senator Cruz Unveils AI Framework and Regulatory Sandbox Bill

The United States and Colombia have historically maintained a strong bilateral partnership that has been the envy of much of Latin America. However, the bilateral relationship today is facing a test as U.S. and Colombian approaches to shared problems increasingly diverge. The next several months present milestones that will have

Continue Reading U.S.-Colombia Relations Facing Key Decision Points with Implications for Businesses

On September 2, 2025, the U.S. Commerce Department, Bureau of Industry and Security (“BIS”) published in the Federal Register a final rule titled Relaxing Export Controls for Syria (the “Syria Export Controls Rule”). The rule eases certain export controls applicable to Syria under the Export Administration Regulations (“EAR”) by adding

Continue Reading U.S. Commerce Department Eases Export Control Restrictions for Syria

We have reached the six-month anniversary of President Trump’s landmark executive order that extended the regulatory review process run by the White House’s Office of Information and Regulatory Affairs (OIRA) to regulations issued by independent agencies.[1]  This order marked an important change for many companies, especially in the financial services and energy sectors, whose regulators are now subject to White House regulatory review for the first time.

President Trump’s order left open many questions about how OIRA review of independent agency rules would work in practice.  Here at the six-month mark, we have seen enough such reviews to begin to answer these questions.  The bottom line for business is that OIRA and the independent agencies have begun to work out a harmonious relationship.  The independent agencies have acquiesced in OIRA review; indeed, nearly all major independent regulators have by now submitted rules for review.  Reviews—far from imposing major delays on independent agency rulemaking, as some feared—have been remarkably speedy, with both OIRA and the agencies themselves willing to dispense with formalities to expedite reviews.  In short, OIRA review is being integrated into the regulatory process of the independent agencies without undue disruption.Continue Reading OIRA Review of Independent Agency Rulemakings: What We Know So Far

On July 23, the White House released its AI Action Plan, outlining the key priorities of the Trump Administration’s AI policy agenda.  In parallel, President Trump signed three AI executive orders directing the Executive Branch to implement the AI Action Plan’s policies on “Preventing Woke AI in

Continue Reading Trump Administration Issues AI Action Plan and Series of AI Executive Orders

On July 17, 2025, Senators Ed Markey (D-MA) and Cory Booker (D-NJ) introduced the “Ensuring Safe and Toxic-Free Foods Act of 2025.” If enacted, this bill would fundamentally reshape FDA’s generally recognized as safe (GRAS) framework by, among other things, requiring that companies submit GRAS notifications for all ingredients currently

Continue Reading Senators Introduce Bill that would Fundamentally Reshape FDA’s GRAS Framework